trial
as of 2026-07-01Acceptability and Efficacy of Group Reminiscence Intervention in a Sample of Patients With Schizophrenia
NCTId NCT07512843
at a glance
— · Completed
Enrollment 38 (actual)
Sponsored by The Hashemite University
Primary completion 2025-08-29
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
38 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2025-02-01
Primary completion
2025-08-29
Eligibility
ALL · 18 Years · 64 Years
Interventions & indications
Sponsors
The Hashemite UniversityLead Sponsor
Investigators
1
Abdallah Abu khait, Ph.D., RN, PMHCNS, MSN, BSNPrincipal Investigator
Sites
1 total
Zarqa, Jordan
Facts & assertions
4 sourced
Enrollment
38
Phase
NA
Primary Completion Date
2025-08-29
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
indication
investigator